A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

A recent study from Yale School of Public Health and other institutions has found that the diabetes drug rosiglitazone is ...

The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity.

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

A recent study from Karolinska Institutet suggests that a type of diabetes medication called GLP-1 agonists could reduce the ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Learn how diabetes medications could revolutionize stroke prevention and enhance heart and brain health with breakthrough ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

As insulin prices in the United States continue to rise, making it increasingly difficult for diabetic patients to afford ...